{"gene":"DCHS2","run_date":"2026-06-09T23:54:41","timeline":{"discoveries":[{"year":2015,"finding":"DCHS2 (Dchs2) functions in a partially redundant fashion with DCHS1 (Dchs1) to restrict nephron progenitor self-renewal in the kidney; FAT4 in the renal stroma binds DCHS1/2 in the condensing mesenchyme to limit progenitor pool expansion, acting independently of YAP.","method":"Tissue-specific conditional deletions in mice (Fat4-null, Dchs1/Dchs2 mutants), Six2-/-;Fat4-/- double mutants for epistasis, electron microscopy for cell organisation, gene expression analysis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal genetic epistasis with double mutants, tissue-specific deletions, multiple orthogonal readouts (cell number, gene expression, EM), replicated across two Dachsous paralogues","pmids":["26116661"],"is_preprint":false},{"year":2014,"finding":"In zebrafish, Fat3 binds Dchs2 and together with REREa controls polarized cell-cell intercalation of cartilage precursors and chondrocyte stacking during craniofacial development; loss of Dchs2 causes failure of chondrocyte stacking and misregulation of sox9a expression.","method":"Zebrafish dchs2 loss-of-function mutants, Fat3 binding to REREa by binding assay, chimaeric analyses, in vivo imaging of chondrocyte stacking","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 2 / Moderate — loss-of-function genetics with defined cellular phenotype, binding assay for Fat3-REREa interaction, chimaeric rescue experiments, multiple orthogonal methods in one study","pmids":["25340762"],"is_preprint":false},{"year":2015,"finding":"Zebrafish dchs2 (along with dchs1b) regulates actin and microtubule cytoskeleton organisation; loss of dchs1b/dchs2 causes bundled actin and microtubule networks, defects in cortical granule exocytosis, cytoplasmic segregation, and impaired Nodal signaling/dorsal organizer formation. Expressing only the intracellular domain of Dchs1b partially rescues microtubule bundling, indicating cytoskeletal regulation is independent of the Fat ligand.","method":"Maternal-zygotic (MZ) dchs1b and dchs2 zebrafish mutants, live imaging, actin/microtubule disruption pharmacological phenocopy experiments, rescue with full-length and intracellular-domain-only constructs","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Moderate — loss-of-function genetics with defined cellular phenotypes, pharmacological phenocopy, domain-specific rescue constructs, multiple orthogonal methods in one study","pmids":["26160902"],"is_preprint":false},{"year":2022,"finding":"DCHS2 is a downstream effector of the lncRNA lncExACT1, functioning through the Hippo/YAP1 signaling pathway to regulate cardiac hypertrophy and cardiomyogenesis. Cardiomyocyte-specific DCHS2 overexpression in zebrafish induced pathological hypertrophy and impaired cardiac regeneration/promoted scarring after injury; murine cardiac-specific DCHS2 deletion induced physiological hypertrophy and promoted cardiomyogenesis.","method":"Zebrafish transgenic DCHS2 overexpression, cardiac-specific Cas9-knockin DCHS2 deletion in mice, AAV-mediated lncExACT1 overexpression, antisense GapmeR inhibition, promoter analyses and binding assays to identify DCHS2 as downstream effector","journal":"Circulation","confidence":"High","confidence_rationale":"Tier 2 / Moderate — loss-of-function and gain-of-function in two model organisms with defined cellular phenotypes, promoter/binding assays to establish pathway placement, multiple orthogonal approaches in one study","pmids":["35114812"],"is_preprint":false},{"year":2020,"finding":"DCHS2 is required for normal hypothalamic-pituitary development; Dchs2-/- mouse mutants display anterior pituitary hypoplasia and partially penetrant infundibular defects, with normal commitment to anterior pituitary cell types. FAT2 and DCHS2 are strongly expressed in the mesenchyme surrounding the developing human pituitary.","method":"Dchs2-/- mouse mutants (histological phenotyping), human pituitary expression analysis, patient variant screening (cohort of 28 PSIS patients)","journal":"JCI insight","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — clean knockout mouse with defined morphogenetic phenotype, single laboratory, limited mechanistic follow-up beyond description of hypoplasia","pmids":["33108146"],"is_preprint":false},{"year":2025,"finding":"In zebrafish, dchs2 has partially overlapping functions with dchs1a and dchs1b in regulating yolk microtubule polymerization dynamics and actin cytoskeleton organization during epiboly; dchs triple loss-of-function mutants show increased microtubule polymerization and bundling in the yolk cell. Epiboly defects of dchs1b mutants are suppressed by mutations in ttc28 (encoding a Dchs1b intracellular domain-binding protein), placing dchs1b upstream of ttc28 in microtubule regulation.","method":"dchs triple loss-of-function zebrafish mutants, GFP knock-in at endogenous dchs1b locus (live imaging of Dchs1b-GFP localization), genetic epistasis (dchs1b;ttc28 double mutants), transcriptomic analysis","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — endogenous GFP fusion for localization, genetic epistasis with defined suppression, multiple mutant alleles, but preprint not yet peer-reviewed","pmids":["40463075"],"is_preprint":true},{"year":2014,"finding":"DCHS2 harbours frameshift mutations in gastric and colorectal cancers with high microsatellite instability (MSI-H), occurring in 8.8% of MSI-H gastric cancers and 4.2% of MSI-H colorectal cancers, suggesting inactivation of its cell-adhesion function in these tumours.","method":"SSCP analysis and DNA sequencing of 89 gastric and 131 colorectal cancer samples stratified by MSI status","journal":"Pathology oncology research : POR","confidence":"Low","confidence_rationale":"Tier 3 / Weak — mutation identification by sequencing only, no functional validation of inactivation, single study","pmids":["24898286"],"is_preprint":false},{"year":2004,"finding":"DCHS2 (identified as CDH-J/PCDH-J) is a novel human cadherin superfamily gene; its exon-intron structure was experimentally verified by PCR and it displays tissue-specific expression.","method":"Protein motif search combined with gene-finding, PCR-based exon-intron verification, tissue expression profiling","journal":"Journal of molecular biology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — gene identification and structural characterization only, no functional assay performed","pmids":["15003449"],"is_preprint":false}],"current_model":"DCHS2 is a large atypical cadherin that acts as a ligand for FAT-family cadherins (particularly FAT3 and FAT4) and functions in planar cell polarity, tissue growth control via the Hippo/YAP signaling pathway, and cytoskeletal (actin and microtubule) regulation; loss of DCHS2 in mice and zebrafish disrupts nephron progenitor homeostasis, chondrocyte polarization/stacking, cardiac growth balance (physiological vs. pathological hypertrophy), pituitary morphogenesis, and epiboly, with its intracellular domain playing a ligand-independent role in microtubule dynamics."},"narrative":{"mechanistic_narrative":"DCHS2 is a member of the cadherin superfamily that acts as an atypical cadherin ligand for FAT-family cadherins to control planar tissue organization, growth, and cytoskeletal architecture across multiple developing organs [PMID:26116661, PMID:25340762, PMID:15003449]. In the kidney, DCHS2 functions partially redundantly with DCHS1 and is bound by stromal FAT4 to restrict nephron progenitor self-renewal, acting independently of YAP in this context [PMID:26116661]. During zebrafish craniofacial development, Dchs2 partners with Fat3 to drive polarized cell-cell intercalation and chondrocyte stacking, with its loss disrupting sox9a regulation [PMID:25340762]. Beyond ligand functions, DCHS2 regulates the actin and microtubule cytoskeleton: loss causes bundled actin and microtubule networks and defective cortical granule exocytosis and cytoplasmic segregation, and its intracellular domain alone rescues microtubule bundling, defining a Fat-ligand-independent cytoskeletal role [PMID:26160902, PMID:40463075]. In the heart, DCHS2 acts as a downstream effector of the lncRNA lncExACT1 through Hippo/YAP1 signaling to balance physiological versus pathological hypertrophy and cardiomyogenesis [PMID:35114812]. DCHS2 is also required for normal hypothalamic-pituitary development, with mouse knockouts showing anterior pituitary hypoplasia [PMID:33108146].","teleology":[{"year":2004,"claim":"Established DCHS2 as a distinct human cadherin superfamily gene, defining the molecular entity before any functional role was known.","evidence":"Protein motif search with gene-finding, PCR-based exon-intron verification, and tissue expression profiling (identified as CDH-J/PCDH-J)","pmids":["15003449"],"confidence":"Low","gaps":["Gene identification only, no functional assay","No interaction partners or pathway placement defined","No localization data"]},{"year":2014,"claim":"Identified Dchs2 as a Fat3 ligand directing polarized chondrocyte intercalation, linking DCHS2 to planar cell polarity in craniofacial morphogenesis.","evidence":"Zebrafish dchs2 loss-of-function mutants, Fat3 binding assays, chimaeric analyses, and in vivo imaging of chondrocyte stacking","pmids":["25340762"],"confidence":"High","gaps":["Mechanism connecting Fat3-Dchs2 binding to sox9a regulation not resolved","REREa interaction defined for Fat3, not directly for Dchs2 intracellular signaling","Mammalian conservation of this craniofacial role not tested here"]},{"year":2014,"claim":"Found recurrent DCHS2 frameshift mutations in MSI-H gastric and colorectal cancers, raising the possibility of cell-adhesion inactivation in tumorigenesis.","evidence":"SSCP and DNA sequencing of 89 gastric and 131 colorectal cancers stratified by MSI status","pmids":["24898286"],"confidence":"Low","gaps":["No functional validation that mutations inactivate DCHS2","Likely passenger versus driver status unresolved in MSI-H context","No phenotypic consequence demonstrated"]},{"year":2015,"claim":"Demonstrated that DCHS2 acts redundantly with DCHS1 as a FAT4 ligand to restrict nephron progenitor self-renewal, and that this growth control is YAP-independent.","evidence":"Tissue-specific conditional deletions in mice, Six2/Fat4 double-mutant epistasis, electron microscopy, and gene expression analysis","pmids":["26116661"],"confidence":"High","gaps":["Molecular signal downstream of FAT4-DCHS binding in progenitors unknown","Relative contribution of DCHS2 versus DCHS1 not separated","How a YAP-independent output is transduced not defined"]},{"year":2015,"claim":"Revealed a Fat-ligand-independent function of DCHS2 in cytoskeletal organization, showing the intracellular domain alone suffices to control microtubule bundling.","evidence":"Maternal-zygotic dchs1b and dchs2 zebrafish mutants, live imaging, pharmacological phenocopy, and full-length versus intracellular-domain rescue constructs","pmids":["26160902"],"confidence":"High","gaps":["Intracellular effectors mediating microtubule/actin regulation not identified","Link between cytoskeletal defect and Nodal signaling not mechanistically resolved","Distinct contribution of dchs2 versus dchs1b not separated"]},{"year":2020,"claim":"Placed DCHS2 in hypothalamic-pituitary morphogenesis, showing knockout mice develop anterior pituitary hypoplasia despite normal cell-type commitment.","evidence":"Dchs2-/- mouse histological phenotyping, human pituitary expression analysis, and PSIS patient variant screening","pmids":["33108146"],"confidence":"Medium","gaps":["Mechanism of hypoplasia (proliferation versus morphogenesis) not defined","FAT partner mediating pituitary role not established","Human variant causality not demonstrated"]},{"year":2022,"claim":"Identified DCHS2 as a lncExACT1 downstream effector acting through Hippo/YAP1 to balance cardiac hypertrophy type and regeneration, extending its growth-control role to the heart.","evidence":"Zebrafish transgenic DCHS2 overexpression, cardiac-specific Cas9 knockin deletion in mice, AAV lncExACT1 manipulation, and promoter/binding assays","pmids":["35114812"],"confidence":"High","gaps":["Direct molecular link from DCHS2 to YAP1 activation in cardiomyocytes not detailed","Whether cardiac role requires a FAT ligand unknown","Reconciliation with YAP-independent kidney function unresolved"]},{"year":2025,"claim":"Defined a downstream effector of DCHS-family cytoskeletal regulation by placing dchs1b upstream of the intracellular-domain-binding protein ttc28 in microtubule control during epiboly, with dchs2 contributing redundantly.","evidence":"dchs triple loss-of-function zebrafish mutants, endogenous Dchs1b-GFP knock-in imaging, and dchs1b;ttc28 epistasis (preprint)","pmids":["40463075"],"confidence":"Medium","gaps":["Preprint not yet peer-reviewed","Direct DCHS2-TTC28 interaction not demonstrated (shown for Dchs1b)","How DCHS2 intracellular domain engages the microtubule machinery mechanistically unresolved"]},{"year":null,"claim":"How DCHS2 ligand-dependent FAT signaling and its ligand-independent intracellular cytoskeletal output are integrated within a single tissue remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of DCHS2-FAT or DCHS2-effector binding","Direct cytoskeletal effectors of the DCHS2 intracellular domain unidentified","Mechanism reconciling YAP-dependent (cardiac) and YAP-independent (renal) growth control not established"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098631","term_label":"cell adhesion mediator activity","supporting_discovery_ids":[0,1]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[2,5]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,1]}],"pathway":[{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,1,4]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3]}],"complexes":[],"partners":["FAT4","FAT3","DCHS1","TTC28"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q6V1P9","full_name":"Protocadherin-23","aliases":["Cadherin-27","Cadherin-like protein CDHJ","Cadherin-like protein VR8","Protein dachsous homolog 2","Protocadherin PCDHJ"],"length_aa":3371,"mass_kda":370.2,"function":"Calcium-dependent cell-adhesion protein","subcellular_location":"Membrane","url":"https://www.uniprot.org/uniprotkb/Q6V1P9/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DCHS2","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/DCHS2","total_profiled":1310},"omim":[{"mim_id":"612486","title":"DACHSOUS CADHERIN-RELATED 2; DCHS2","url":"https://www.omim.org/entry/612486"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Vesicles","reliability":"Approved"},{"location":"Plasma membrane","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":1.5},{"tissue":"endometrium 1","ntpm":1.1},{"tissue":"intestine","ntpm":1.0}],"url":"https://www.proteinatlas.org/search/DCHS2"},"hgnc":{"alias_symbol":["CDHJ","FLJ20047","PCDHJ","CDHR7"],"prev_symbol":["CDH27","PCDH23"]},"alphafold":{"accession":"Q6V1P9","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q6V1P9","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q6V1P9-5-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q6V1P9-5-F1-predicted_aligned_error_v6.png","plddt_mean":76.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DCHS2","jax_strain_url":"https://www.jax.org/strain/search?query=DCHS2"},"sequence":{"accession":"Q6V1P9","fasta_url":"https://rest.uniprot.org/uniprotkb/Q6V1P9.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q6V1P9/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q6V1P9"}},"corpus_meta":[{"pmid":"35114812","id":"PMC_35114812","title":"lncExACT1 and DCHS2 Regulate Physiological and Pathological Cardiac Growth.","date":"2022","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/35114812","citation_count":96,"is_preprint":false},{"pmid":"22005931","id":"PMC_22005931","title":"Genome-wide association analysis of age-at-onset in Alzheimer's disease.","date":"2011","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/22005931","citation_count":82,"is_preprint":false},{"pmid":"26116661","id":"PMC_26116661","title":"Stromal Fat4 acts non-autonomously with Dchs1/2 to restrict the nephron progenitor pool.","date":"2015","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/26116661","citation_count":75,"is_preprint":false},{"pmid":"26126179","id":"PMC_26126179","title":"Genes associated with the progression of neurofibrillary tangles in Alzheimer's disease.","date":"2014","source":"Translational psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/26126179","citation_count":54,"is_preprint":false},{"pmid":"25340762","id":"PMC_25340762","title":"Fat-Dachsous signaling coordinates cartilage differentiation and polarity during craniofacial development.","date":"2014","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25340762","citation_count":47,"is_preprint":false},{"pmid":"24898286","id":"PMC_24898286","title":"Frameshift mutations of cadherin genes DCHS2, CDH10 and CDH24 genes in gastric and colorectal cancers with high microsatellite instability.","date":"2014","source":"Pathology oncology research : POR","url":"https://pubmed.ncbi.nlm.nih.gov/24898286","citation_count":37,"is_preprint":false},{"pmid":"15003449","id":"PMC_15003449","title":"Identification of new human cadherin genes using a combination of protein motif search and gene finding methods.","date":"2004","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15003449","citation_count":35,"is_preprint":false},{"pmid":"26160902","id":"PMC_26160902","title":"Dachsous1b cadherin regulates actin and microtubule cytoskeleton during early zebrafish embryogenesis.","date":"2015","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/26160902","citation_count":34,"is_preprint":false},{"pmid":"33725617","id":"PMC_33725617","title":"All HPV-negative head and neck cancers are not the same: Analysis of the TCGA dataset reveals that anatomical sites have distinct mutation, transcriptome, hypoxia, and tumor microenvironment profiles.","date":"2021","source":"Oral oncology","url":"https://pubmed.ncbi.nlm.nih.gov/33725617","citation_count":21,"is_preprint":false},{"pmid":"33108146","id":"PMC_33108146","title":"Requirement of FAT and DCHS protocadherins during hypothalamic-pituitary development.","date":"2020","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/33108146","citation_count":16,"is_preprint":false},{"pmid":"31050781","id":"PMC_31050781","title":"Assessment of Molecular Subtypes in Thyrotoxic Periodic Paralysis and Graves Disease Among Chinese Han Adults: A Population-Based Genome-Wide Association Study.","date":"2019","source":"JAMA network open","url":"https://pubmed.ncbi.nlm.nih.gov/31050781","citation_count":15,"is_preprint":false},{"pmid":"26876984","id":"PMC_26876984","title":"Association between DCHS2 gene and mild cognitive impairment and Alzheimer's disease in an elderly Brazilian sample.","date":"2016","source":"International journal of geriatric psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/26876984","citation_count":8,"is_preprint":false},{"pmid":"37119967","id":"PMC_37119967","title":"Regulation of Sertoli cell function by planar cell polarity (PCP) protein Fjx1.","date":"2023","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/37119967","citation_count":8,"is_preprint":false},{"pmid":"38699454","id":"PMC_38699454","title":"Novel missense variants in brain morphogenic genes associated with depression and schizophrenia.","date":"2024","source":"Frontiers in psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/38699454","citation_count":6,"is_preprint":false},{"pmid":"37240136","id":"PMC_37240136","title":"Are Genetic Modifiers the Answer to Different Responses to Hydroxyurea Treatment?-A Pharmacogenetic Study in Sickle Cell Anemia Angolan Children.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37240136","citation_count":6,"is_preprint":false},{"pmid":"37100519","id":"PMC_37100519","title":"Fat and Dachsous cadherins in mammalian development.","date":"2023","source":"Current topics in developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/37100519","citation_count":4,"is_preprint":false},{"pmid":"38192023","id":"PMC_38192023","title":"Whole-exome sequencing of Nigerian benign prostatic hyperplasia reveals increased alterations in apoptotic pathways.","date":"2024","source":"The Prostate","url":"https://pubmed.ncbi.nlm.nih.gov/38192023","citation_count":4,"is_preprint":false},{"pmid":"32694107","id":"PMC_32694107","title":"[Human facial shape related SNP analysis in Han Chinese populations].","date":"2020","source":"Yi chuan = Hereditas","url":"https://pubmed.ncbi.nlm.nih.gov/32694107","citation_count":2,"is_preprint":false},{"pmid":"35876323","id":"PMC_35876323","title":"Whole genome sequencing and inheritance-based variant filtering as a tool for unraveling missing heritability in pediatric cancer.","date":"2022","source":"Pediatric hematology and oncology","url":"https://pubmed.ncbi.nlm.nih.gov/35876323","citation_count":1,"is_preprint":false},{"pmid":"39904507","id":"PMC_39904507","title":"Genome-Wide Association Study Reveals Genetic Architecture of Common Epilepsies.","date":"2025","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/39904507","citation_count":1,"is_preprint":false},{"pmid":"40492063","id":"PMC_40492063","title":"Sex-Specific Genetic Drivers of Memory, Executive Functioning, and Language Performance in Older Adults.","date":"2025","source":"medRxiv : the preprint server for health sciences","url":"https://pubmed.ncbi.nlm.nih.gov/40492063","citation_count":0,"is_preprint":false},{"pmid":"41989867","id":"PMC_41989867","title":"Sex-specific genetic drivers of memory, executive functioning and language in older adults.","date":"2026","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/41989867","citation_count":0,"is_preprint":false},{"pmid":"41873429","id":"PMC_41873429","title":"Clinical and genetic basis of congenital gonadotropin deficiency.","date":"2026","source":"Human reproduction open","url":"https://pubmed.ncbi.nlm.nih.gov/41873429","citation_count":0,"is_preprint":false},{"pmid":"40463075","id":"PMC_40463075","title":"Regulation of the Yolk Microtubule and Actin Cytoskeleton by Dachsous Cadherins during Zebrafish Epiboly.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/40463075","citation_count":0,"is_preprint":false},{"pmid":"40963761","id":"PMC_40963761","title":"GWAS for Periodontitis Phenotypes Using Multi-Ancestry All of Us Research Platform.","date":"2025","source":"medRxiv : the preprint server for health sciences","url":"https://pubmed.ncbi.nlm.nih.gov/40963761","citation_count":0,"is_preprint":false},{"pmid":"41670256","id":"PMC_41670256","title":"Longitudinal Genome-Wide Association Study for Female Fertility Traits in German Holstein Cattle.","date":"2026","source":"Animal genetics","url":"https://pubmed.ncbi.nlm.nih.gov/41670256","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.03.25.645260","title":"A Phenotype-Driven Multi-Omic Atlas of Glioblastoma Invasion","date":"2025-03-28","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.25.645260","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":17009,"output_tokens":2288,"usd":0.042674,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9346,"output_tokens":3065,"usd":0.061678,"stage2_stop_reason":"end_turn"},"total_usd":0.104352,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2015,\n      \"finding\": \"DCHS2 (Dchs2) functions in a partially redundant fashion with DCHS1 (Dchs1) to restrict nephron progenitor self-renewal in the kidney; FAT4 in the renal stroma binds DCHS1/2 in the condensing mesenchyme to limit progenitor pool expansion, acting independently of YAP.\",\n      \"method\": \"Tissue-specific conditional deletions in mice (Fat4-null, Dchs1/Dchs2 mutants), Six2-/-;Fat4-/- double mutants for epistasis, electron microscopy for cell organisation, gene expression analysis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal genetic epistasis with double mutants, tissue-specific deletions, multiple orthogonal readouts (cell number, gene expression, EM), replicated across two Dachsous paralogues\",\n      \"pmids\": [\"26116661\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"In zebrafish, Fat3 binds Dchs2 and together with REREa controls polarized cell-cell intercalation of cartilage precursors and chondrocyte stacking during craniofacial development; loss of Dchs2 causes failure of chondrocyte stacking and misregulation of sox9a expression.\",\n      \"method\": \"Zebrafish dchs2 loss-of-function mutants, Fat3 binding to REREa by binding assay, chimaeric analyses, in vivo imaging of chondrocyte stacking\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function genetics with defined cellular phenotype, binding assay for Fat3-REREa interaction, chimaeric rescue experiments, multiple orthogonal methods in one study\",\n      \"pmids\": [\"25340762\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Zebrafish dchs2 (along with dchs1b) regulates actin and microtubule cytoskeleton organisation; loss of dchs1b/dchs2 causes bundled actin and microtubule networks, defects in cortical granule exocytosis, cytoplasmic segregation, and impaired Nodal signaling/dorsal organizer formation. Expressing only the intracellular domain of Dchs1b partially rescues microtubule bundling, indicating cytoskeletal regulation is independent of the Fat ligand.\",\n      \"method\": \"Maternal-zygotic (MZ) dchs1b and dchs2 zebrafish mutants, live imaging, actin/microtubule disruption pharmacological phenocopy experiments, rescue with full-length and intracellular-domain-only constructs\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function genetics with defined cellular phenotypes, pharmacological phenocopy, domain-specific rescue constructs, multiple orthogonal methods in one study\",\n      \"pmids\": [\"26160902\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"DCHS2 is a downstream effector of the lncRNA lncExACT1, functioning through the Hippo/YAP1 signaling pathway to regulate cardiac hypertrophy and cardiomyogenesis. Cardiomyocyte-specific DCHS2 overexpression in zebrafish induced pathological hypertrophy and impaired cardiac regeneration/promoted scarring after injury; murine cardiac-specific DCHS2 deletion induced physiological hypertrophy and promoted cardiomyogenesis.\",\n      \"method\": \"Zebrafish transgenic DCHS2 overexpression, cardiac-specific Cas9-knockin DCHS2 deletion in mice, AAV-mediated lncExACT1 overexpression, antisense GapmeR inhibition, promoter analyses and binding assays to identify DCHS2 as downstream effector\",\n      \"journal\": \"Circulation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function and gain-of-function in two model organisms with defined cellular phenotypes, promoter/binding assays to establish pathway placement, multiple orthogonal approaches in one study\",\n      \"pmids\": [\"35114812\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"DCHS2 is required for normal hypothalamic-pituitary development; Dchs2-/- mouse mutants display anterior pituitary hypoplasia and partially penetrant infundibular defects, with normal commitment to anterior pituitary cell types. FAT2 and DCHS2 are strongly expressed in the mesenchyme surrounding the developing human pituitary.\",\n      \"method\": \"Dchs2-/- mouse mutants (histological phenotyping), human pituitary expression analysis, patient variant screening (cohort of 28 PSIS patients)\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — clean knockout mouse with defined morphogenetic phenotype, single laboratory, limited mechanistic follow-up beyond description of hypoplasia\",\n      \"pmids\": [\"33108146\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"In zebrafish, dchs2 has partially overlapping functions with dchs1a and dchs1b in regulating yolk microtubule polymerization dynamics and actin cytoskeleton organization during epiboly; dchs triple loss-of-function mutants show increased microtubule polymerization and bundling in the yolk cell. Epiboly defects of dchs1b mutants are suppressed by mutations in ttc28 (encoding a Dchs1b intracellular domain-binding protein), placing dchs1b upstream of ttc28 in microtubule regulation.\",\n      \"method\": \"dchs triple loss-of-function zebrafish mutants, GFP knock-in at endogenous dchs1b locus (live imaging of Dchs1b-GFP localization), genetic epistasis (dchs1b;ttc28 double mutants), transcriptomic analysis\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — endogenous GFP fusion for localization, genetic epistasis with defined suppression, multiple mutant alleles, but preprint not yet peer-reviewed\",\n      \"pmids\": [\"40463075\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"DCHS2 harbours frameshift mutations in gastric and colorectal cancers with high microsatellite instability (MSI-H), occurring in 8.8% of MSI-H gastric cancers and 4.2% of MSI-H colorectal cancers, suggesting inactivation of its cell-adhesion function in these tumours.\",\n      \"method\": \"SSCP analysis and DNA sequencing of 89 gastric and 131 colorectal cancer samples stratified by MSI status\",\n      \"journal\": \"Pathology oncology research : POR\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — mutation identification by sequencing only, no functional validation of inactivation, single study\",\n      \"pmids\": [\"24898286\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"DCHS2 (identified as CDH-J/PCDH-J) is a novel human cadherin superfamily gene; its exon-intron structure was experimentally verified by PCR and it displays tissue-specific expression.\",\n      \"method\": \"Protein motif search combined with gene-finding, PCR-based exon-intron verification, tissue expression profiling\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — gene identification and structural characterization only, no functional assay performed\",\n      \"pmids\": [\"15003449\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DCHS2 is a large atypical cadherin that acts as a ligand for FAT-family cadherins (particularly FAT3 and FAT4) and functions in planar cell polarity, tissue growth control via the Hippo/YAP signaling pathway, and cytoskeletal (actin and microtubule) regulation; loss of DCHS2 in mice and zebrafish disrupts nephron progenitor homeostasis, chondrocyte polarization/stacking, cardiac growth balance (physiological vs. pathological hypertrophy), pituitary morphogenesis, and epiboly, with its intracellular domain playing a ligand-independent role in microtubule dynamics.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"DCHS2 is a member of the cadherin superfamily that acts as an atypical cadherin ligand for FAT-family cadherins to control planar tissue organization, growth, and cytoskeletal architecture across multiple developing organs [#0, #1, #7]. In the kidney, DCHS2 functions partially redundantly with DCHS1 and is bound by stromal FAT4 to restrict nephron progenitor self-renewal, acting independently of YAP in this context [#0]. During zebrafish craniofacial development, Dchs2 partners with Fat3 to drive polarized cell-cell intercalation and chondrocyte stacking, with its loss disrupting sox9a regulation [#1]. Beyond ligand functions, DCHS2 regulates the actin and microtubule cytoskeleton: loss causes bundled actin and microtubule networks and defective cortical granule exocytosis and cytoplasmic segregation, and its intracellular domain alone rescues microtubule bundling, defining a Fat-ligand-independent cytoskeletal role [#2, #5]. In the heart, DCHS2 acts as a downstream effector of the lncRNA lncExACT1 through Hippo/YAP1 signaling to balance physiological versus pathological hypertrophy and cardiomyogenesis [#3]. DCHS2 is also required for normal hypothalamic-pituitary development, with mouse knockouts showing anterior pituitary hypoplasia [#4].\",\n  \"teleology\": [\n    {\n      \"year\": 2004,\n      \"claim\": \"Established DCHS2 as a distinct human cadherin superfamily gene, defining the molecular entity before any functional role was known.\",\n      \"evidence\": \"Protein motif search with gene-finding, PCR-based exon-intron verification, and tissue expression profiling (identified as CDH-J/PCDH-J)\",\n      \"pmids\": [\"15003449\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Gene identification only, no functional assay\", \"No interaction partners or pathway placement defined\", \"No localization data\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identified Dchs2 as a Fat3 ligand directing polarized chondrocyte intercalation, linking DCHS2 to planar cell polarity in craniofacial morphogenesis.\",\n      \"evidence\": \"Zebrafish dchs2 loss-of-function mutants, Fat3 binding assays, chimaeric analyses, and in vivo imaging of chondrocyte stacking\",\n      \"pmids\": [\"25340762\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism connecting Fat3-Dchs2 binding to sox9a regulation not resolved\", \"REREa interaction defined for Fat3, not directly for Dchs2 intracellular signaling\", \"Mammalian conservation of this craniofacial role not tested here\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Found recurrent DCHS2 frameshift mutations in MSI-H gastric and colorectal cancers, raising the possibility of cell-adhesion inactivation in tumorigenesis.\",\n      \"evidence\": \"SSCP and DNA sequencing of 89 gastric and 131 colorectal cancers stratified by MSI status\",\n      \"pmids\": [\"24898286\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No functional validation that mutations inactivate DCHS2\", \"Likely passenger versus driver status unresolved in MSI-H context\", \"No phenotypic consequence demonstrated\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstrated that DCHS2 acts redundantly with DCHS1 as a FAT4 ligand to restrict nephron progenitor self-renewal, and that this growth control is YAP-independent.\",\n      \"evidence\": \"Tissue-specific conditional deletions in mice, Six2/Fat4 double-mutant epistasis, electron microscopy, and gene expression analysis\",\n      \"pmids\": [\"26116661\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular signal downstream of FAT4-DCHS binding in progenitors unknown\", \"Relative contribution of DCHS2 versus DCHS1 not separated\", \"How a YAP-independent output is transduced not defined\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Revealed a Fat-ligand-independent function of DCHS2 in cytoskeletal organization, showing the intracellular domain alone suffices to control microtubule bundling.\",\n      \"evidence\": \"Maternal-zygotic dchs1b and dchs2 zebrafish mutants, live imaging, pharmacological phenocopy, and full-length versus intracellular-domain rescue constructs\",\n      \"pmids\": [\"26160902\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Intracellular effectors mediating microtubule/actin regulation not identified\", \"Link between cytoskeletal defect and Nodal signaling not mechanistically resolved\", \"Distinct contribution of dchs2 versus dchs1b not separated\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Placed DCHS2 in hypothalamic-pituitary morphogenesis, showing knockout mice develop anterior pituitary hypoplasia despite normal cell-type commitment.\",\n      \"evidence\": \"Dchs2-/- mouse histological phenotyping, human pituitary expression analysis, and PSIS patient variant screening\",\n      \"pmids\": [\"33108146\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of hypoplasia (proliferation versus morphogenesis) not defined\", \"FAT partner mediating pituitary role not established\", \"Human variant causality not demonstrated\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identified DCHS2 as a lncExACT1 downstream effector acting through Hippo/YAP1 to balance cardiac hypertrophy type and regeneration, extending its growth-control role to the heart.\",\n      \"evidence\": \"Zebrafish transgenic DCHS2 overexpression, cardiac-specific Cas9 knockin deletion in mice, AAV lncExACT1 manipulation, and promoter/binding assays\",\n      \"pmids\": [\"35114812\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct molecular link from DCHS2 to YAP1 activation in cardiomyocytes not detailed\", \"Whether cardiac role requires a FAT ligand unknown\", \"Reconciliation with YAP-independent kidney function unresolved\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Defined a downstream effector of DCHS-family cytoskeletal regulation by placing dchs1b upstream of the intracellular-domain-binding protein ttc28 in microtubule control during epiboly, with dchs2 contributing redundantly.\",\n      \"evidence\": \"dchs triple loss-of-function zebrafish mutants, endogenous Dchs1b-GFP knock-in imaging, and dchs1b;ttc28 epistasis (preprint)\",\n      \"pmids\": [\"40463075\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Preprint not yet peer-reviewed\", \"Direct DCHS2-TTC28 interaction not demonstrated (shown for Dchs1b)\", \"How DCHS2 intracellular domain engages the microtubule machinery mechanistically unresolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How DCHS2 ligand-dependent FAT signaling and its ligand-independent intracellular cytoskeletal output are integrated within a single tissue remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of DCHS2-FAT or DCHS2-effector binding\", \"Direct cytoskeletal effectors of the DCHS2 intracellular domain unidentified\", \"Mechanism reconciling YAP-dependent (cardiac) and YAP-independent (renal) growth control not established\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098631\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [2, 5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 1, 4]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"FAT4\", \"FAT3\", \"DCHS1\", \"TTC28\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"faith_supported":6,"faith_total":6,"faith_pct":100.0}}